Cathy Davies

3.3k total citations · 2 hit papers
41 papers, 2.1k citations indexed

About

Cathy Davies is a scholar working on Psychiatry and Mental health, Social Psychology and Philosophy. According to data from OpenAlex, Cathy Davies has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Psychiatry and Mental health, 11 papers in Social Psychology and 11 papers in Philosophy. Recurrent topics in Cathy Davies's work include Schizophrenia research and treatment (22 papers), Mental Health and Psychiatry (11 papers) and Cannabis and Cannabinoid Research (8 papers). Cathy Davies is often cited by papers focused on Schizophrenia research and treatment (22 papers), Mental Health and Psychiatry (11 papers) and Cannabis and Cannabinoid Research (8 papers). Cathy Davies collaborates with scholars based in United Kingdom, Italy and Spain. Cathy Davies's co-authors include Paolo Fusar‐Poli, Philip McGuire, Dominic Oliver, Daniel Ståhl, Joaquim Raduà, Grazia Rutigliano, Ilaria Bonoldi, Valentina Ramella‐Cravaro, John P. A. Ioannidis and Sagnik Bhattacharyya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience & Biobehavioral Reviews and Psychological Medicine.

In The Last Decade

Cathy Davies

39 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What causes psychosis? An umbrella review of risk and protective factors

2018 383 citations Joaquim Raduà, Valentina Ramella‐Cravaro et al. profile →
Transdiagnostic psychiatry: a systematic review

2019 250 citations Paolo Fusar‐Poli, Marco Solmi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathy Davies United Kingdom	19	1.3k	608	506	413	376	41	2.1k
Jesús Pérez United Kingdom	29	1.6k 1.2×	696 1.1×	427 0.8×	408 1.0×	420 1.1×	125	2.6k
Nomi Werbeloff Israel	23	1.2k 0.9×	909 1.5×	296 0.6×	374 0.9×	337 0.9×	65	2.1k
Matteo Rocchetti Italy	24	1.5k 1.1×	711 1.2×	435 0.9×	484 1.2×	458 1.2×	55	2.5k
Olesya Ajnakina United Kingdom	21	1.0k 0.8×	480 0.8×	341 0.7×	241 0.6×	265 0.7×	55	1.9k
Anja Vaskinn Norway	28	1.8k 1.4×	773 1.3×	420 0.8×	488 1.2×	221 0.6×	86	2.6k
Ann Færden Norway	24	1.3k 1.0×	596 1.0×	310 0.6×	286 0.7×	212 0.6×	57	1.9k
Alp Üçok Türkiye	31	1.8k 1.4×	1.1k 1.7×	438 0.9×	262 0.6×	480 1.3×	99	2.7k
Somaia Mohamed United States	27	1.8k 1.4×	966 1.6×	493 1.0×	312 0.8×	402 1.1×	77	2.9k
Kelly Allott Australia	33	2.1k 1.6×	951 1.6×	628 1.2×	686 1.7×	356 0.9×	157	3.1k
Petter Andreas Ringen Norway	25	1.7k 1.3×	510 0.8×	239 0.5×	217 0.5×	165 0.4×	52	2.3k

Countries citing papers authored by Cathy Davies

Since Specialization

Citations

This map shows the geographic impact of Cathy Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Davies more than expected).

Fields of papers citing papers by Cathy Davies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Davies. The network helps show where Cathy Davies may publish in the future.

Co-authorship network of co-authors of Cathy Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Davies. A scholar is included among the top collaborators of Cathy Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Davies. Cathy Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhattacharyya, Sagnik, Cathy Davies, Ben Carter, et al.. (2024). Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT. SHILAP Revista de lepidopterología. 1–17.

Oliver, Dominic, Edward Chesney, Alexis E. Cullen, et al.. (2024). Exploring causal mechanisms of psychosis risk. Neuroscience & Biobehavioral Reviews. 162. 105699–105699. 10 indexed citations

Oliver, Dominic, Cathy Davies, Fernando Zelaya, et al.. (2023). Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study. Frontiers in Psychiatry. 14. 1092213–1092213. 3 indexed citations

Davies, Cathy, Matthijs G. Bossong, Daniel Martins, et al.. (2023). Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol. Psychological Medicine. 54(5). 993–1003. 4 indexed citations

Navacerrada, Maria Elisa Serrano, Eugene Kim, Karen Randall, et al.. (2022). Erbb4Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes. Schizophrenia Bulletin. 49(3). 569–580. 6 indexed citations

Pablo, Gonzalo Salazar de, Cathy Davies, Marco Solmi, et al.. (2021). Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis. European Psychiatry. 64(1). e51–e51. 8 indexed citations

Gomes, Felipe V., Diana Cash, Daniela L. Uliana, et al.. (2021). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology. 47(3). 687–695. 9 indexed citations

Davies, Cathy, et al.. (2021). GABA, Glutamate and Neural Activity: A Systematic Review With Meta-Analysis of Multimodal 1H-MRS-fMRI Studies. Frontiers in Psychiatry. 12. 644315–644315. 43 indexed citations

Davies, Cathy, Elizabeth Appiah‐Kusi, Robin Wilson, et al.. (2021). Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report. European Archives of Psychiatry and Clinical Neuroscience. 272(3). 461–475. 14 indexed citations

10.

Martins, Daniel, Cathy Davies, Andrea De Micheli, et al.. (2020). Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study. Translational Psychiatry. 10(1). 227–227. 17 indexed citations

11.

Davies, Cathy, Yannis Paloyelis, Grazia Rutigliano, et al.. (2019). Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis. Neuropsychopharmacology. 44(7). 1300–1309. 23 indexed citations

12.

Davies, Cathy, Grazia Rutigliano, Andrea De Micheli, et al.. (2019). Neurochemical effects of oxytocin in people at clinical high risk for psychosis. European Neuropsychopharmacology. 29(5). 601–615. 5 indexed citations

13.

Fusar‐Poli, Paolo, Cathy Davies, Marco Solmi, et al.. (2019). Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence). Frontiers in Psychiatry. 10. 764–764. 68 indexed citations

14.

Minichino, Amedeo, Grazia Rutigliano, Cathy Davies, et al.. (2019). Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services. European Psychiatry. 57. 26–32. 33 indexed citations

15.

Fusar‐Poli, Paolo, Cathy Davies, Grazia Rutigliano, et al.. (2019). Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age. Frontiers in Psychiatry. 10. 313–313. 17 indexed citations

16.

Rutigliano, Grazia, Amedeo Minichino, Rashmi Patel, et al.. (2018). Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions. European Psychiatry. 52. 126–133. 31 indexed citations

17.

Davies, Cathy, Joaquim Raduà, Andrea Cipriani, et al.. (2018). Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis. Frontiers in Psychiatry. 9. 187–187. 74 indexed citations

18.

Murray, Robin, Amir Englund, Anissa Abi‐Dargham, et al.. (2017). Cannabis-associated psychosis: Neural substrate and clinical impact. Neuropharmacology. 124. 89–104. 123 indexed citations

19.

Fusar‐Poli, Paolo, Grazia Rutigliano, Daniel Ståhl, et al.. (2016). Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders. European Psychiatry. 42. 49–54. 87 indexed citations

20.

Davies, Cathy, R.J.S. Chinn, Mark Nelson, et al.. (2007). Outcome in AIDS-Related Systemic Non-Hodgkin Lymphoma and Leptomeningeal Disease Is Not Predicted by a CT Brain Scan. American Journal of Neuroradiology. 28(10). 1988–1990. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact